Ferric Maltol

Ferric Maltol

Products

Information

Ferric maltol is an advanced oral iron therapy featuring a stable 3:1 complex of ferric iron (Fe3+) and maltol, a naturally occurring sugar derivative. This unique composition enhances iron absorption in the small intestine, offering superior bioavailability compared to traditional iron supplements like ferrous sulfate. It provides efficient iron uptake at lower doses, minimizing common gastrointestinal side effects such as constipation, nausea, and abdominal discomfort, which often lead to poor patient compliance. Particularly useful in managing iron-deficiency anemia in patients with chronic conditions like inflammatory bowel disease (IBD) and chronic kidney disease (CKD), ferric maltol improves tolerability. Clinical studies show it effectively increases hemoglobin levels and maintains improvements for up to 64 weeks, supporting long-term treatment. Oral administration eliminates the need for invasive intravenous therapies, reducing risks of infusion reactions. Ferric maltol has a favorable safety profile with minimal drug interactions, making it suitable for diverse populations, including pregnant women and those with malabsorption issues. Additionally, emerging research suggests that maltol may have antioxidant properties, potentially offering protective effects against oxidative stress. Preliminary studies also hint at cognitive benefits, as iron is crucial for neurological function, benefiting those with iron-deficiency-related cognitive impairments. With a simple dosing schedule (typically 30 mg twice daily), ferric maltol enhances patient adherence compared to traditional iron salts. Its stability in various pH environments ensures consistent absorption, even in patients with altered gut physiology. Overall, ferric maltol is a patient-friendly, well-tolerated, and effective option for addressing iron-deficiency anemia.
Product Category
Active Pharmaceutical Ingredients
West Bengal Chemical Industries LimitedH3.C10English Overview: Established in 1962, West Bengal Chemical Industries Limited (WBCIL) is a leading WHO-GMP certified and ISO 9001:2015 accredited manufacturer based in India. With over six decades of expertise WBCIL specializes in the production of mineral-based APIs, chelated minerals, complex salts, advanced nutraceutical ingredients and Injectable Iron. WBCIL operates two state-of-the-art manufacturing facilities in Kolkata (West Bengal) and Dahej (Gujarat), serving more than 35 countries across pharmaceutical, nutraceutical, food, and animal health sectors. Both sites are compliant with global quality and regulatory norms including WHO-GMP, HACCP, and are equipped to provide Kosher and Halal certifications as per customer requirements. A central pillar of WBCIL’s innovation is its Liposomal Nutraceuticals Portfolio, which includes Liposomal Iron, Calcium, Zinc, and Magnesium. These formulations are engineered to deliver significantly higher bioavailability, improved absorption, and minimal gastrointestinal irritation compared to conventional mineral forms. The liposomal delivery system enhances cellular uptake, positioning these products as ideal choices for preventive and therapeutic health formulations. WBCIL’s innovation is backed by a strong in-house R&D team and a robust intellectual property portfolio with 12 patented molecules — each developed to address specific clinical, formulation, or bioavailability challenges. Further strengthening its regulatory profile, WBCIL holds 7 Written Confirmations (WCs) issued by the Indian authorities, allowing compliant export of APIs to the European Union. The company also provides Drug Master Files (DMFs) in CTD format, with selected dossiers already submitted to the USFDA and other international regulatory bodies. The company’s extensive mineral API portfolio includes a wide range of chelates, complexes, and direct compressible (DC) granules of Iron, Calcium, Magnesium, Potassium, Zinc, Copper, and trace elements like Manganese, Chromium, Selenium, and Boron. WBCIL specializes in highly bioavailable, acid-resistant, and low-heavy-metal forms such as bisglycinates, citrates, ascorbates, and aspartates. In addition to pharmaceutical and nutraceutical-grade products, WBCIL also offers a specialized range of fine chemicals and organic molecules for food applications and animal nutrition, including sodium butyrate, calcium butyrate, and mineral glycinates. With a deep commitment to quality, compliance, and customer-centric innovation, WBCIL continues to be a preferred partner for global companies looking for reliable, differentiated, and science-backed solutions in the field of mineral APIs and nutraceuticals. Aperçu en français : Fondée en 1962, West Bengal Chemical Industries Limited (WBCIL) est un fabricant leader, certifié WHO-GMP et accrédité ISO 9001:2015, basé en Inde. Fort de plus de six décennies d'expertise, WBCIL se spécialise dans la production d'APIs à base de minéraux, de minéraux chélatés, de sels complexes, d'ingrédients nutraceutiques avancés et de fer injectable. WBCIL exploite deux installations de fabrication de pointe à Kolkata (Bengale occidental) et à Dahej (Gujarat), desservant plus de 35 pays dans les secteurs pharmaceutique, nutraceutique, alimentaire et de la santé animale. Les deux sites sont conformes aux normes mondiales de qualité et aux exigences réglementaires, y compris WHO-GMP, HACCP, et sont équipés pour fournir des certifications Kasher et Halal selon les exigences des clients. Un pilier central de l'innovation de WBCIL est son portefeuille de nutraceutiques liposomaux, qui comprend le fer liposomal, le calcium liposomal, le zinc liposomal et le magnésium liposomal. Ces formulations sont conçues pour offrir une biodisponibilité significativement plus élevée, une meilleure absorption et une irritation gastro-intestinale minimale par rapport aux formes minérales conventionnelles. Le système de livraison liposomal améliore l'absorption cellulaire, positionnant ces produits comme des choix idéaux pour les formulations de santé préventives et thérapeutiques. L'innovation de WBCIL est soutenue par une équipe de R&D interne solide et un portefeuille de propriété intellectuelle robuste avec 12 molécules brevetées, chacune développée pour répondre à des défis cliniques, de formulation ou de biodisponibilité spécifiques. Renforçant davantage son profil réglementaire, WBCIL détient 7 confirmations écrites (CE) émises par les autorités indiennes, permettant l'exportation conforme des APIs vers l'Union européenne. L'entreprise fournit également des Dossiers Maîtres de Médicaments (DMF) au format CTD, avec certains dossiers déjà soumis à la USFDA et à d'autres autorités réglementaires internationales. Le large portefeuille d'APIs minérales de l'entreprise comprend une grande variété de chélates, complexes et de granulés compressibles directs (DC) de fer, calcium, magnésium, potassium, zinc, cuivre, ainsi que des oligo-éléments tels que le manganèse, le chrome, le sélénium et le bore. WBCIL se spécialise dans des formes hautement biodisponibles, résistantes aux acides et à faibles teneurs en métaux lourds, telles que les bisglycinates, citrates, ascorbates et aspartates. En plus des produits pharmaceutiques et nutraceutiques, WBCIL propose également une gamme spécialisée de produits chimiques fins et de molécules organiques pour les applications alimentaires et la nutrition animale, incluant le butyrate de sodium, le butyrate de calcium et des glycinates minéraux. Avec un engagement profond envers la qualité, la conformité et l'innovation centrée sur le client, WBCIL continue d'être un partenaire privilégié pour les entreprises mondiales recherchant des solutions fiables, différenciées et soutenues par la science dans le domaine des APIs minérales et des nutraceutiques.

Join the event!

See all the content and easy-to-use features by logging in or registering!